Aptevo Therapeutics Inc. 4
4 · Aptevo Therapeutics Inc. · Filed Jun 1, 2017
Insider Transaction Report
Form 4
Maddux Randy Joe
Senior VP, Operations
Transactions
- Award
Employee Stock Option (right to buy)
2017-06-01+33,700→ 33,700 totalExercise: $2.15Exp: 2027-05-31→ Common Stock (33,700 underlying)
Footnotes (2)
- [F1]The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017.
- [F2]The option vests in three equal annual installments beginning on June 1, 2018.